ARA-290 Peptide: The Complete Guide - Uses, Mechanism, Dosing, Safety & Research
ARA-290, also known by its INN cibinetide, is a synthetic 11-amino acid peptide engineered from the helix B surface domain of human erythropoietin (EPO). It was designed to isolate EPO's tissue-protective and neuroprotective activity from its red blood cell-producing function, binding selectively to the Innate Repair Receptor (IRR) without triggering erythropoiesis. This guide covers what ARA-290 does, how it works, what the Phase 2 clinical trial data shows, dosing context from research, its safety profile, regulatory status, and how it compares to other neuroprotective compounds.
Ara 290
26 min read
